Xiong Junjie, He Du, Hu Weiming, Liu Xubao
Department of Pancreatic Surgery Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Medicine (Baltimore). 2017 Mar;96(12):e6452. doi: 10.1097/MD.0000000000006452.
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide and the incidence is increasing as a result of growing hepatitis B and C virus infections. Primary clear cell carcinoma of the liver (PCCCL) is a rare subgroup of primary HCC, which has low metastatic potential and infrequently reported in literature. Retroperitoneal and intrahepatic metastasis of PCCCL has not been reported previously.
Here, we present a 55-year-old male with retroperitoneal and intrahepatic metastasis of PCCCL who is managed with surgical method and transcatheter arterial chemoembolization (TACE) at our institution. When the patient is followed up in 16 months after surgery and TACE, he is alive without any extrahepatic metastasis and abnomal liver function.
We concluded that surgical resection of retroperitoneal metastasis and TACE of the intrahepatic tumors provided an appropriate strategy for the patient with unresectable PCCCL accompanied with extra-hepatic metastasis.
肝细胞癌(HCC)是全球癌症相关死亡的主要原因,由于乙型和丙型肝炎病毒感染的增加,其发病率正在上升。原发性肝透明细胞癌(PCCCL)是原发性肝癌的一个罕见亚组,转移潜能低,文献报道较少。PCCCL的腹膜后和肝内转移此前尚未见报道。
在此,我们报告一名55岁男性,患有PCCCL的腹膜后和肝内转移,在我们机构接受了手术治疗和经动脉化疗栓塞术(TACE)。患者在手术和TACE后16个月随访时,存活且无肝外转移及肝功能异常。
我们得出结论,对于伴有肝外转移的不可切除PCCCL患者,手术切除腹膜后转移灶和肝内肿瘤的TACE提供了一种合适的策略。